Backus, L I <br/><br/>
Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  08 2016 
 - 400-10 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.13696  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Adult<br/>Black or African American<br/>Aged<br/>Aged, 80 and over<br/>Anilides--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Benzimidazoles--therapeutic use<br/>Carbamates--therapeutic use<br/>Cyclopropanes<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Female<br/>Fluorenes--therapeutic use<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--blood<br/>Humans<br/>Lactams, Macrocyclic<br/>Macrocyclic Compounds--therapeutic use<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>RNA, Viral--blood<br/>Ribavirin--therapeutic use<br/>Ritonavir--therapeutic use<br/>Sofosbuvir--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Sustained Virologic Response<br/>Uracil--analogs & derivatives<br/>Valine<br/>Young Adult